These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30597563)

  • 61. Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study.
    Litton E; Baker S; Erber W; Farmer S; Ferrier J; French C; Gummer J; Hawkins D; Higgins A; Hofmann A; De Keulenaer B; McMorrow J; Olynyk JK; Richards T; Towler S; Trengove R; Webb S; ;
    J Intensive Care; 2018; 6():60. PubMed ID: 30214812
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome.
    Zipperer E; Post JG; Herkert M; Kündgen A; Fox F; Haas R; Gattermann N; Germing U
    Ann Hematol; 2013 Dec; 92(12):1617-23. PubMed ID: 23842708
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Short-Term Effects of Blood Transfusions on Hepcidin in Preterm Infants.
    Lorenz L; Müller KF; Poets CF; Peter A; Olbina G; Westerman M; Franz AR
    Neonatology; 2015; 108(3):205-10. PubMed ID: 26304233
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alterations of red blood cell shape and sialic acid membrane content in septic patients.
    Piagnerelli M; Boudjeltia KZ; Brohee D; Piro P; Carlier E; Vincent JL; Lejeune P; Vanhaeverbeek M
    Crit Care Med; 2003 Aug; 31(8):2156-62. PubMed ID: 12973174
    [TBL] [Abstract][Full Text] [Related]  

  • 66. RBC transfusion practices among critically ill patients: has evidence changed practice?
    Murphy DJ; Needham DM; Netzer G; Zeger SL; Colantuoni E; Ness P; Pronovost PJ; Berenholtz SM
    Crit Care Med; 2013 Oct; 41(10):2344-53. PubMed ID: 23939350
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.
    Jain M; Joharapurkar A; Patel V; Kshirsagar S; Sutariya B; Patel M; Patel H; Patel PR
    Eur J Pharmacol; 2019 Jan; 843():113-120. PubMed ID: 30458168
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study.
    Vermeulen Windsant IC; de Wit NC; Sertorio JT; Beckers EA; Tanus-Santos JE; Jacobs MJ; Buurman WA
    Crit Care; 2012 May; 16(3):R95. PubMed ID: 22624585
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transfusion practice in the critically ill.
    Corwin HL; Surgenor SD; Gettinger A
    Crit Care Med; 2003 Dec; 31(12 Suppl):S668-71. PubMed ID: 14724464
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fresh Red Cells for Transfusion in Critically Ill Adults: An Economic Evaluation of the Standard Issue Transfusion Versus Fresher Red-Cell Use in Intensive Care (TRANSFUSE) Clinical Trial.
    Irving A; Higgins A; Ady B; Bellomo R; Cooper DJ; French C; Gantner D; Harris A; Irving DO; Murray L; Nichol A; Petrie D; McQuilten ZK;
    Crit Care Med; 2019 Jul; 47(7):e572-e579. PubMed ID: 31008734
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transfusion of 35-day stored red blood cells does not result in increase of plasma non-transferrin bound iron in human endotoxemia.
    Peters AL; Kunanayagam RK; van Bruggen R; de Korte D; Juffermans NP; Vlaar AP
    Transfusion; 2017 Jan; 57(1):53-59. PubMed ID: 27696454
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recommendations on RBC Transfusion in Critically Ill Children With Acute Brain Injury From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.
    Tasker RC; Turgeon AF; Spinella PC; ;
    Pediatr Crit Care Med; 2018 Sep; 19(9S Suppl 1):S133-S136. PubMed ID: 30161068
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of IL-10 on iron metabolism in LPS-induced inflammatory mice via modulating hepcidin expression.
    Huang P; Wang J; Lin X; Yang FF; Tan JH
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3469-3475. PubMed ID: 28829493
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Red blood cell transfusion decision making in critically ill children.
    Lacroix J; Tucci M; Du Pont-Thibodeau G
    Curr Opin Pediatr; 2015 Jun; 27(3):286-91. PubMed ID: 25888151
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
    Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association between leukoreduced red blood cell transfusions and hospital-acquired infections in critically ill children: A secondary analysis of the TRIPICU study.
    Flatman LK; Fergusson DA; Lacroix J; Ducruet T; Papenburg J; Fontela PS
    Vox Sang; 2022 Apr; 117(4):545-552. PubMed ID: 34820856
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients.
    Hariri G; Bourcier S; Marjanovic Z; Joffre J; Lemarié J; Lavillegrand JR; Charue D; Duflot T; Bigé N; Baudel JL; Maury E; Mohty M; Guidet B; Bellien J; Blanc-Brude O; Ait-Oufella H
    Crit Care; 2019 Aug; 23(1):292. PubMed ID: 31470888
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Leukoreduced blood transfusion does not increase circulating soluble markers of inflammation: a randomized controlled trial.
    Jiwaji Z; Nunn KP; Conway-Morris A; Simpson AJ; Wyncoll D; Rossi AG; Walsh TS;
    Transfusion; 2014 Oct; 54(10):2404-11. PubMed ID: 24796937
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recommendations on the Indications for RBC Transfusion for the Critically Ill Child Receiving Support From Extracorporeal Membrane Oxygenation, Ventricular Assist, and Renal Replacement Therapy Devices From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.
    Bembea MM; Cheifetz IM; Fortenberry JD; Bunchman TE; Valentine SL; Bateman ST; Steiner ME; ;
    Pediatr Crit Care Med; 2018 Sep; 19(9S Suppl 1):S157-S162. PubMed ID: 30161071
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Respiratory Dysfunction Associated With RBC Transfusion in Critically Ill Children: A Prospective Cohort Study.
    Kleiber N; Lefebvre É; Gauvin F; Tucci M; Robitaille N; Trottier H; Jouvet P; Ducruet T; Poitras N; Lacroix J; Emeriaud G
    Pediatr Crit Care Med; 2015 May; 16(4):325-34. PubMed ID: 25647237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.